Evidence map›Paper›PMID 28387772›Full record

ArticleThe ISME journal2017

Class 1 integrons are low-cost structures in Escherichia coli.

Yohann Lacotte, Marie-Cécile Ploy, Sophie Raherison

Open access · bronzeAbstract read
In one paragraph

Article in The ISME journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. mSystems · 2024
    Article
  7. Article
  8. Detecting Class 1 Integrons and Their Variable Regions inAntibiotics (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Dominance ofMicrobial genomics · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. AAntibiotics (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Genetic and Ecological Diversity ofFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yohann LacotteUniversité de Limoges, INSERM, CHU Limoges, UMR_S 1092, Limoges, France.
Marie-Cécile PloyUniversité de Limoges, INSERM, CHU Limoges, UMR_S 1092, Limoges, France.
Sophie RaherisonUniversité de Limoges, INSERM, CHU Limoges, UMR_S 1092, Limoges, France.
Inserm · FRUniversité de Limoges · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance integrons are bacterial genetic platforms that can capture and express antibiotic resistance genes embedded within gene cassettes. The capture and shuffling of gene cassettes are mediated by the integrase IntI, the expression of which is regulated by the SOS response in Escherichia coli. Gene cassettes are expressed from a common Pc promoter. Despite the clinical and environmental relevance of integrons, the selective forces responsible for their evolution and maintenance are poorly understood. Here, we conducted pairwise competition experiments in order to assess the fitness cost of class 1 integrons in E. coli. We found that integrons are low-cost structures and that their cost is further reduced by their tight regulation. We show that the SOS response prevents the expression of costly integrases whose cost is activity dependent. Thus, when an integron is repressed, its cost depends mostly on the expression of its gene cassettes array and increases with Pc strength and the number of cassettes in the array. Furthermore, different cassettes have different costs. Lastly, we showed that subinhibitory antibiotic concentrations promoted the selection of integron-carrying bacteria, especially those with a strong Pc promoter. These results provide new insights into the evolutionary dynamics of integron-carrying bacterial populations.

Indexed as

Anti-Bacterial AgentsBiological EvolutionEscherichia coliGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicIntegrasesIntegronsPromoter Regions, GeneticSOS Response, GeneticsAnti-Bacterial AgentsIntegrases

Identifiers

PMID28387772
PMCPMC5520156
OpenAlexW2604897194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.